immunotherapy

Researchers use mRNA to create cancer vaccines that are personalized to each individual’s unique tumor.

How are scientists incorporating oncolytic viruses into the current cancer treatment landscape? 

Cancer anywhere in the body can change brain activity, and brain activity can drive cancer growth. These surprising discoveries are leading to new treatments.

Pioneering approaches transform vaccine technologies and shape the future of disease prevention.

Natural killer cells offer safe and effective cancer treatment, but to succeed in the clinic, they need a bit of an energy boost.

Immunologist Gabriel Rabinovich leverages his 30 years of experience studying sugar-binding proteins, galectins, for developing novel therapies.

Screening 12,000 genes helped researchers develop new generation CAR T cells for cancer therapy.

Understanding the complex three-way communication between immune cells, the gut microbiome, and cancer sheds light on why immunotherapies fail in some patients but succeed in others.

Chimeric antigen receptor engineering is now possible for immune cells other than T cells, including macrophages and invariant natural killer T cells.

By removing immunosuppressive factors from the blood, researchers hope to give the immune system a fighting chance against advanced tumors.